| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a39ae0101872ecaa4b63b356bc27ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cd7029ec038fa78d4b371f9bf08e9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca923ca8d28074b4d2c37cca45af0f0c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c8e3b56bf9d1f9c70cba6d5f129f1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd85c8b95997363baba51f9d0067d01d |
| publicationDate |
2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012138857-A2 |
| titleOfInvention |
Methods and materials for reducing supression of immune function |
| abstract |
This document provides methods and materials involved in reducing suppression of immune function in mammals. For example, methods and materials for (a) identifying a mammal as having an elevated level of CD14 + /DR - cells (e.g., CD14 + /DR - monocytes) and (b) administering RU486 (mifepristone; or drugs with a similar functional profile) to the identified mammal under conditions that change the ratio of CD14 + /HLA-DR - cells to CD14+/HLA-DR+ cells as well as methods and materials for (a) identifying a mammal as being likely to experience an elevated level of CD14 + /DR - cells (e.g., CD14 + /DR - monocytes) and (b) administering RU486 (mifepristone; or drugs with a similar functional profile) to the identified mammal under conditions that reduce the degree to which the mammal develops CD14 + /DR - cells are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9970936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014182761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9733248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10670601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11143653-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10094835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10234458-B2 |
| priorityDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |